Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
- IMblaze370 Investigators
- University of Texas MD Anderson Cancer Center
- University of Ulsan
- Sarah Cannon Research Institute
- Vall d'Hebron Institute of Oncology
- Austin Health
- IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano
- Pisa University Hospital
- City of Hope National Med Center
- The University of Chicago
- Memorial Sloan-Kettering Cancer Center
- University Eye Clinic
- Genentech, Inc
- University of Campania Luigi Vanvitelli
Research output: Contribution to journal › Article › peer-review
497
Link opens in a new tab
Scopus
citations